Literature DB >> 2961683

Altered T-cell subsets and defective T-cell function in young children with Down syndrome (trisomy-21).

R L Noble1, R P Warren.   

Abstract

Children with Down syndrome (DS) suffer an increased incidence of severe viral and bacterial infections particularly during the first 5 years of life. Unfortunately, few studies have been performed on the immune systems of young children with Down syndrome. Peripheral blood mononuclear cells (PBMC) from a group of non-institutionalized children less than 6 years of age were studied and compared with PBMC from age-matched controls. The children with DS had reduced numbers of circulating OKT4+ (helper/inducer) T cells and a significantly depressed ratio of OKT4+ to OKT8+ (suppressor/cytotoxic) T cells. PBMC from the DS subjects exhibited reduced proliferative responses to phytohemagglutinin and to an optimal concentration of concanavalin A (Con A), but normal responses to suboptimal doses of Con A and pokeweek mitogen. PBMC from young children with DS appeared to produce normal levels of interleukin-2 (IL-2). These findings provide evidence that the primary immune defect in DS is in part a depressed number and function of helper T cells. They also indicate that IL-2 production may not be defective in DS, but rather that the mechanism for response to IL-2 may be faulty.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2961683     DOI: 10.3109/08820138709087092

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  1 in total

1.  Direct analysis of thymic function in children with Down's syndrome.

Authors:  Nicole Prada; Milena Nasi; Leonarda Troiano; Erika Roat; Marcello Pinti; Elisa Nemes; Enrico Lugli; Roberta Ferraresi; Luigi Ciacci; Davide Bertoni; Ornella Biagioni; Milena Gibertoni; Cristina Cornia; Liviana Meschiari; Elisabetta Gramazio; Mauro Mariotti; Ugo Consolo; Fiorella Balli; Andrea Cossarizza
Journal:  Immun Ageing       Date:  2005-02-16       Impact factor: 6.400

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.